The Washington State Court of Appeal reversed and remanded a product liability suit against Hyland’s Naturals on Monday after determining that the trial court improperly applied the Frye standard to exclude testimony from a doctor who concluded that the company’s tablets “‘more likely than not’” caused the death of a 13-month-old child.
Tanessa Desranleau sued Hyland’s after her son, Jay’Breon Bush Desranleau, died in his crib in January 2014. In the days before his death, Desranleau’s son had a cold, and she gave him “Baby Tiny Cold Tablets,” a homeopathic cold remedy manufactured by the company. The tablets contain Gelsemium sempervirens, a medicinal herb, which Desranleau claims caused her son’s death.
